semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Overweight and Obesity Signature of consent informed Men and Women ≥ 18 years old proven through a current official identification BMI ≥ 30 kg/m2 with or without Comorbidities BMI ≥ 27 kg/m2 with a diagnosis of comorbidities by patient's clinical record associated with overweight (DM2's recent diagnosis without treatment, hypertension, dyslipidemia, sleep apnea or secondary heart disease) defined as follows DM2 of current diagnosis study unless not receive drug treatment, with a HbA1c ≥6. 5 and and < 8.5% Arterial Systemic Hypertension with figures < 140 / 90 mmHg Dyslipidemia with total cholesterol levels> 200 mg / dl and <240 mg / dl, and / or LDL-C> 100 and <160 mg / dl and / or triglycerides> 150 mg / dl and <400 mg / dl In case of have drug treatment for hypertension or dyslipidemia, the participants must have a stable dose for at least 3 months prior to the elective visit Women in childbearing age must use a reliable method of birth control, such as barrier methods (condom, diaphragm), fallopian tube obstruction, intrauterine device  Endogenous obesity (endocrine diseases that condition gain of weight, such as hypothyroidism, syndrome of Cushing) Background of patient's clinical record history of iatrogenic obesity (use of drugs that determine weight gain, such as corticosteroids, antipsychotic and antiepileptic) Thyroid stimulating Hormone (TSH) is out of range Prolongation of the QT interval corrected for rate (QTc) segment by electrocardiogram with the formula of prolonged Bazett (greater than 450 msec. in males and 470 msec in women) Creatinine ≥1. 3 mg/dl in women and ≥1. 5 mg/dl in men Alanine transaminase(ALT) or Aspartate Aminotransferase (AST) > 2 times above from the normal value Background of patient's clinical record of depressive disorder or anxiety that may require therapy with psychiatric drugs Intolerance known to drugs in the study Pregnancy or breastfeeding
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 45.0-75.0,  Obesity Overweight Life Style Non-smokers and weight-stable (± 2 kg, for more than one year) with no history of regular exercise in at least three months before the study  History of CVD and other disorders such as diabetes, depression, eating disorders, chronic medications, kidney disease, cancer, food allergies or intolerances to items used in meals Subjects with abnormality in thyroid or Electrocardiograph, any history of anti-obesity medication or weight loss drugs or dietary supplementations for weight control
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 25.0-50.0,  Obesity Female Age: 25-50y Lean: BMI 19-23 kg/m2, waist circumference <80 cm, and fasting glucose <6.1 mmol/L; Obese: BMI 30-35 kg/m2, waist circumference >88 cm, and fasting glucose >=6.1 and <7.5 mmol/L Healthy as assessed by the NIZO lifestyle and health questionnaire ("Verklaring leefgewoonten en gezondheid") Healthy as assessed by results of the pre-study safety laboratory tests (clinical chemistry: liver/kidney function etc) Regular and normal Dutch eating habits as assessed by the NIZO lifestyle and health questionnaire (3 main meals per day) Regular bowel movement (defecation on average once a day, at least 4 times/week)  Participation in any clinical trial with oral, intravenous or inhalatory administration of any substances during 90 days before study start History or presence of any clinically important disease or disorder which, in the opinion of the Investigator, may either put the subject at risk because of participation in the study, or influence the results or the subject's ability to participate in the study type 1 or type 2 diabetes gastrointestinal disease bariatric surgery cardiovascular disease, liver or renal failure or disease of the thyroid gland, cancer infectious disease, history of chronic active inflammatory disorders or food allergy Use of antibiotics during the one (1) year prior to study start; # Constipation/infrequent bowel movement (defecation <4 times per week) Having diarrhea within 3 months prior to the study start (at least 3 loose stools per day)
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 45.0-65.0,  Exercise Addiction Diet Habit Obesity Overweight Weight Loss Non-smokers and weight-stable (± 2 kg, for more than one year) with no history of regular exercise in at least three months before the study  History of CVD and other disorders such as diabetes, depression, eating disorders, chronic medications, kidney disease, cancer, food allergies or intolerances to items used in meals. Subjects with abnormality in thyroid or Electrocardiograph, any history of anti-obesity medication or weight loss drugs or dietary supplementations for weight control
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 45.0-75.0,  Men Life Style Lipid Metabolism Disorders Obesity Overweight Non-smokers Weight-stable (± 2 kg, for more than one year) No history of regular exercise (in at least three months before the study)  History of medical disorders (CVD and other such as diabetes, depression, eating disorders, chronic medications, kidney disease, cancer, food allergies or intolerances to items used in meals, abnormality in thyroid or Electrocardiograph History of anti-obesity medication or weight loss drugs or dietary supplementations for weight control
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 45.0-75.0,  Men Diet Modification Obesity Overweight Life Style Weight Loss Non-smokers and weight-stable (± 2 kg, for more than one year) with no history of regular exercise in at least three months before the study  History of CVD and other disorders such as diabetes, depression, eating disorders, chronic medications, kidney disease, cancer, food allergies or intolerances to items used in meals. Subjects with abnormality in thyroid or Electrocardiograph, any history of anti-obesity medication or weight loss drugs or dietary supplementations for weight control
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 35.0-64.0,  Obese Electronic Screener Data (EMR): 1. Aged 35 to 64 years. 2. Female. 3. BMI ≥ 30. 4. Healthy-Me referral or Eligible for Healthy-Me Self-reported Screener Data: 5. English as primary language. 6. Self-identified non-Hispanic black or African-American, or non-Hispanic white. 7. A permanent address  Electronic Screener Data (EMR): 1. Severe illness that might be associated with weight loss, such as cancer. 2. Use of weight loss medications (rare due to cost of the medications). 3. History of bipolar disorder or psychosis. Self-reported Screener Data: 4. Severe cognitive impairment (≥3 errors on a 6-item cognitive screen). 5. Unwilling or unable to provide informed consent. 6. Bariatric surgery already completed or planned within 12 months. 7. Pregnant or nursing in past 6 months, or plans to become so within 12 months. 8. Residence outside of Marion County, Indiana. 9. Substance abuse (for alcohol; ≥2 on CAGE questionnaire). 10. Current smoking or tobacco use
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Muscle Tone Abnormalities Healthy Volunteers Older than 18 years Bilateral shortened hamstrings muscles with a knee extension under 60º (TEAR, Neto et al., 2015) and a ROM under 80º in the hip (straight leg raise test angle, Espejo-Antúnez et al., 2015)  Participation in a muscular stretching program during the study Previous history of surgical intervention in the hip, tight or knee Muscle-skeletal pain or injury in the low back or inferior limbs Abdominal o spine surgery within three month before the study beginning. Exit Patient´s petition Change in the regular physical activity level during the study period Appearance of an injury that would contraindicate the use of stretching techniques
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 14.0-50.0,  Contraception Fluent English or Spanish speaking Delivered during current admission to hospital Postpartum day 1 or post-op day 1 or 2  Females less than 14 years of age Status post sterilization or hysterectomy Received an intrauterine device immediately after delivery (postplacental) Does not have a smartphone capable of browsing the internet
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-69.0,  Obesity Generally healthy subjects (men and women ≥ 18 and ≤ 69 years old) were required to be overweight or obese (BMI ≥ 27 kg/m2 and ≤ 50 kg/m2) to exhibit visceral obesity (waist circumference ≥ 35 inches for women and ≥ 39 inches for men) and demonstrate signs of cardiometabolic dysfunction. Specifically, subjects were required to have elevated LDL cholesterol ≥ 130 mg/dl and/or elevated TG defined as TG ≥ 130 mg/dl. Additionally, subjects were required to have at least one of the following (unless subject had both elevated LDL and TG) HDL < 50 mg/dl for women and < 40 mg/dl for men blood glucose ≥ 100 mg/dl, HbA1C ≥ 5.7% or Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) score defined as ≥ 2.0  included Pregnancy Lactation Recent changes in prescription medications, over-the-counter medications, medical foods, and nutritional supplements Recent or regular use of narcotics, investigational drugs, corticosteroids, anticoagulants, neuroactive medications, or medication or supplements relevant to hyperglycemia or hyperlipidemia Chronic use of over-the-counter medication which would interfere with study endpoints including laxatives and antacids Allergy or intolerance to study products Serious, unstable medical conditions including known infection with HIV, tuberculosis or hepatitis; cardiovascular disease; Diabetes Mellitus; autoimmune diseases; malignancy; psychiatric disease; substance abuse Abnormal laboratory findings Participating in or planning to begin a weight loss diet during the study period
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 20.0-65.0,  Bariatric Surgery Candidate Obesity, Morbid body mass index (BMI) ≥ 35 kg/m2 or BMI ≥ 30 kg/m2 with co-morbidities such as hypertension, glucose intolerance, dyslipidemia, and sleep apnea 2. being suitable for general anesthesia 3. being able to give informed consent and committed to follow-up 4. Female patients should have a negative urine pregnancy test at screening and agree to use reliable method of contraception for 1 year  prior bariatric surgery of any kind 2. being unable to understand the risks, benefits and compliance requirements of this trial 3. pregnancy or planning on being pregnancy 4. non-Korean speaker 5. American society of anesthesiology (ASA) class IV or higher 6. malignancy within 5 years
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-40.0,  PCOS pco obese ifertile  no medical disorders no hormonal treatment in the previous 3 months
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Overweight and Obesity Dyslipoproteinemia BMI: between 27.0 and 34.9 kg/m² One of the following blood lipids: total cholesterol ≥ 200 mg/dL, LDL-cholesterol ≥ 175 mg/dL, HDL-cholesterol ≤ 50 mg/dL, TG 150-400 mg/dL women, 18-60 years Specific  lactose or protein intolerance hypo or hyperthyroidism pharmacological treatment of diabetes intake of vitamins or mineral supplements anticoagulants cardiac pacemaker contraindications to exercise
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Vaginosis, Bacterial Women recruited Living with HIV-1 infection At least 18 years of age Receiving antiretroviral therapy Intravaginal practices Vaginal intercourse with men in the month prior to enrolment Living in the Lusaka metropolitan area  Pregnant Being on hormonal contraception Having an intrauterine device (IUD) in place to avoid the potential for induced changes in inflammatory cytokines in the genital mucosa due to contraception